The Evidence-to-Practice Podcast Series: Transitions of Care
What is the Optimal Antiplatelet Therapy Duration After Acute MI?
Tracy Wang, MD, MHS, MSc, and Jeffrey Washam, PharmD, discuss clinical data regarding antiplatelet therapy for acute post-myocardial infarction patients, including questions about medication adherence, triple therapy, and aspirin dosage. They also address a report published in the most recent issue of the Journal of the American College of Cardiology. The study compares the incidence of death, hemorrhage, MI, stent thrombosis, and adverse cardiac events when dual antiplatelet therapy is combined with drug-eluting stents and as part of the long-term therapy of stable post-MI patients.